The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- How Corteva Agriscience is boosting South Africa’s farming system
- AI-driven project targets climate resilient crops for farmers in Africa
- Vice Chancellor urges graduands on digital, media literacy skills
- Ondo varsity expels 15 female students
- Katsina varsity unveils plans for Marine Engineering, Aviation Tech
- US approves arms sales to Israel, Saudi Arabia
- NSCDC hands over fake cryptocurrency investment suspect to EFCC
- Stanbic IBTC records 69% profit earnings
